A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor

Gang Zou; Francesc Puig-Basagoiti; Bo Zhang; Min Qing; Liqiang Chen; Krzysztof W. Pankiewicz; Krzysztof Felczak; Zhiming Yuan; Pei Yong Shi

doi:10.1016/j.virol.2008.11.003

A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor

Gang Zou, Francesc Puig-Basagoiti, Bo Zhang, Min Qing, Liqiang Chen, Krzysztof W. Pankiewicz, Krzysztof Felczak, Zhiming Yuan, Pei Yong Shi

Center for Drug Design

Research output: Contribution to journal › Article › peer-review

112 Scopus citations

Abstract

Lycorine potently inhibits flaviviruses in cell culture. At 1.2-μM concentration, lycorine reduced viral titers of West Nile (WNV), dengue, and yellow fever viruses by 10²- to 10⁴-fold. However, the compound did not inhibit an alphavirus (Western equine encephalitis virus) or a rhabdovirus (vesicular stomatitis virus), indicating a selective antiviral spectrum. The compound exerts its antiviral activity mainly through suppression of viral RNA replication. A Val → Met substitution at the 9th amino acid position of the viral 2K peptide (spanning the endoplasmic reticulum membrane between NS4A and NS4B proteins) confers WNV resistance to lycorine, through enhancement of viral RNA replication. Initial chemistry synthesis demonstrated that modifications of the two hydroxyl groups of lycorine can increase the compound's potency, while reducing its cytotoxicity. Taken together, the results have established lycorine as a flavivirus inhibitor for antiviral development. The lycorine-resistance results demonstrate a direct role of the 2K peptide in flavivirus RNA synthesis.

Original language	English (US)
Pages (from-to)	242-252
Number of pages	11
Journal	Virology
Volume	384
Issue number	1
DOIs	https://doi.org/10.1016/j.virol.2008.11.003
State	Published - Feb 5 2009

Bibliographical note

Funding Information:
We thank Wadsworth Center's Molecular Genetics Core for the DNA sequencing and Cell Culture Facility for the maintenance of BHK-21 and Vero cells. This work was supported partially by federal funds from the National Institute of Allergy and Infectious Disease, National Institutes of Health, under contract NOI-AI-25490, and by NIH grants U01 AI061193 and U54-AI057158 (Northeast Biodefense Center).

Keywords

Antiviral
Flavivirus 2K peptide
Flavivirus replication
Viral resistance
West Nile virus

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.virol.2008.11.003

OpenUrl availability

Full text

Cite this

@article{d605cbe394cf45919a868fbf9450671d,

title = "A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor",

abstract = "Lycorine potently inhibits flaviviruses in cell culture. At 1.2-μM concentration, lycorine reduced viral titers of West Nile (WNV), dengue, and yellow fever viruses by 102- to 104-fold. However, the compound did not inhibit an alphavirus (Western equine encephalitis virus) or a rhabdovirus (vesicular stomatitis virus), indicating a selective antiviral spectrum. The compound exerts its antiviral activity mainly through suppression of viral RNA replication. A Val → Met substitution at the 9th amino acid position of the viral 2K peptide (spanning the endoplasmic reticulum membrane between NS4A and NS4B proteins) confers WNV resistance to lycorine, through enhancement of viral RNA replication. Initial chemistry synthesis demonstrated that modifications of the two hydroxyl groups of lycorine can increase the compound's potency, while reducing its cytotoxicity. Taken together, the results have established lycorine as a flavivirus inhibitor for antiviral development. The lycorine-resistance results demonstrate a direct role of the 2K peptide in flavivirus RNA synthesis.",

keywords = "Antiviral, Flavivirus 2K peptide, Flavivirus replication, Viral resistance, West Nile virus",

author = "Gang Zou and Francesc Puig-Basagoiti and Bo Zhang and Min Qing and Liqiang Chen and Pankiewicz, {Krzysztof W.} and Krzysztof Felczak and Zhiming Yuan and Shi, {Pei Yong}",

note = "Funding Information: We thank Wadsworth Center's Molecular Genetics Core for the DNA sequencing and Cell Culture Facility for the maintenance of BHK-21 and Vero cells. This work was supported partially by federal funds from the National Institute of Allergy and Infectious Disease, National Institutes of Health, under contract NOI-AI-25490, and by NIH grants U01 AI061193 and U54-AI057158 (Northeast Biodefense Center).",

year = "2009",

month = feb,

day = "5",

doi = "10.1016/j.virol.2008.11.003",

language = "English (US)",

volume = "384",

pages = "242--252",

journal = "Virology",

issn = "0042-6822",

publisher = "Academic Press Inc.",

number = "1",

}

TY - JOUR

T1 - A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor

AU - Zou, Gang

AU - Puig-Basagoiti, Francesc

AU - Zhang, Bo

AU - Qing, Min

AU - Chen, Liqiang

AU - Pankiewicz, Krzysztof W.

AU - Felczak, Krzysztof

AU - Yuan, Zhiming

AU - Shi, Pei Yong

N1 - Funding Information: We thank Wadsworth Center's Molecular Genetics Core for the DNA sequencing and Cell Culture Facility for the maintenance of BHK-21 and Vero cells. This work was supported partially by federal funds from the National Institute of Allergy and Infectious Disease, National Institutes of Health, under contract NOI-AI-25490, and by NIH grants U01 AI061193 and U54-AI057158 (Northeast Biodefense Center).

PY - 2009/2/5

Y1 - 2009/2/5

N2 - Lycorine potently inhibits flaviviruses in cell culture. At 1.2-μM concentration, lycorine reduced viral titers of West Nile (WNV), dengue, and yellow fever viruses by 102- to 104-fold. However, the compound did not inhibit an alphavirus (Western equine encephalitis virus) or a rhabdovirus (vesicular stomatitis virus), indicating a selective antiviral spectrum. The compound exerts its antiviral activity mainly through suppression of viral RNA replication. A Val → Met substitution at the 9th amino acid position of the viral 2K peptide (spanning the endoplasmic reticulum membrane between NS4A and NS4B proteins) confers WNV resistance to lycorine, through enhancement of viral RNA replication. Initial chemistry synthesis demonstrated that modifications of the two hydroxyl groups of lycorine can increase the compound's potency, while reducing its cytotoxicity. Taken together, the results have established lycorine as a flavivirus inhibitor for antiviral development. The lycorine-resistance results demonstrate a direct role of the 2K peptide in flavivirus RNA synthesis.

AB - Lycorine potently inhibits flaviviruses in cell culture. At 1.2-μM concentration, lycorine reduced viral titers of West Nile (WNV), dengue, and yellow fever viruses by 102- to 104-fold. However, the compound did not inhibit an alphavirus (Western equine encephalitis virus) or a rhabdovirus (vesicular stomatitis virus), indicating a selective antiviral spectrum. The compound exerts its antiviral activity mainly through suppression of viral RNA replication. A Val → Met substitution at the 9th amino acid position of the viral 2K peptide (spanning the endoplasmic reticulum membrane between NS4A and NS4B proteins) confers WNV resistance to lycorine, through enhancement of viral RNA replication. Initial chemistry synthesis demonstrated that modifications of the two hydroxyl groups of lycorine can increase the compound's potency, while reducing its cytotoxicity. Taken together, the results have established lycorine as a flavivirus inhibitor for antiviral development. The lycorine-resistance results demonstrate a direct role of the 2K peptide in flavivirus RNA synthesis.

KW - Antiviral

KW - Flavivirus 2K peptide

KW - Flavivirus replication

KW - Viral resistance

KW - West Nile virus

UR - http://www.scopus.com/inward/record.url?scp=58649100667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58649100667&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2008.11.003

DO - 10.1016/j.virol.2008.11.003

M3 - Article

C2 - 19062063

AN - SCOPUS:58649100667

SN - 0042-6822

VL - 384

SP - 242

EP - 252

JO - Virology

JF - Virology

IS - 1

ER -

A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this